| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.074 | 0.09 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |